wyszukanych pozycji: 3
Locoregional Radionuclide Cancer Therapy: Clinical and Scientific Aspects
ISBN: 9783030562663 / Angielski / Twarda / 2020 / 268 str. Termin realizacji zamówienia: ok. 20 dni roboczych. |
|
cena:
385,52 zł |
Radiopharmaceuticals in the Management of Leptomeningeal Metastasis
ISBN: 9783031142901 / Angielski / Miękka / 2022 / 232 str. Termin realizacji zamówienia: ok. 20 dni roboczych. This book reviews the current clinical practice of leptomeningeal metastasis (LM) diagnosis and treatment, which is predominately by intrathecal chemotherapy and/or in combination with external beam radiotherapy. LM is a refractory lethal complication of many human malignancies when neoplastic cells grow in the meninges. The use of penetrating emissions from radionuclides has the advantages of visualizing cerebrospinal fluid (CSF) flow and ablating meninges at shallow depths and has been used to diagnose CSF flow anomalies and to treat LM. The scientific bases of using radionuclides...
This book reviews the current clinical practice of leptomeningeal metastasis (LM) diagnosis and treatment, which is predominately by intrathecal chemo...
|
|
cena:
462,63 zł |
Locoregional Radionuclide Cancer Therapy: Clinical and Scientific Aspects
ISBN: 9783030562694 / Angielski / Miękka / 2021 Termin realizacji zamówienia: ok. 20 dni roboczych. This book reviews locoregional radionuclide cancer therapies (LRCT). Proving an increasingly viable alternative to radiotherapy, radionuclide therapy includes a diversity of choices of well characterized biochemical and physiologic target molecules. The delivery and retention of radionuclides may be monitored by advanced imaging for exact tissue localization and for real-time dosimetry to enable personalized precision medicine. Radiopharmaceuticals in human cancer therapies are typically delivered in systemic routes but can also be designed for locoregional routes to harness... This book reviews locoregional radionuclide cancer therapies (LRCT). Proving an increasingly viable alternative to radiotherapy, radionuclide thera... |
|
cena:
385,52 zł |